Shionogi & Co., Ltd.

What's New Index

2010/02/05		Audio Webcasting of Conference Call for the Third Quarter of Fiscal Year 2009
2010/02/01		Financial Results for the Third Quarter of Fiscal Year 2009
2010/01/26		A Novel Anti-viral Drug for Influenza,"RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion" Launch
2010/01/25		Shionogi Supports Relief Efforts for Haiti Earthquake Victims
2010/01/20		Shionogi Receives Marketing and Manufacturing Approval of an Antidepressant Drug,"Cymbalta ®Capsules 20mg and 30mg"
2010/01/13		Shionogi Receives Marketing and Manufacturing Approval of a Novel Anti-viral Drug for Influenza, "RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion"
2010/01/12		SCIELE PHARMA, INC., A SHIONOGI GROUP COMPANY, ANNOUNCES NAME CHANGE
2010/01/07		Sciele Pharma introduces Adrenaclick auto-injector for the emergency treatment of anaphylaxis
2009/11/19		Sciele Pharma presents PSD502 clinical data for the treatment of premature ejaculation at a medical conference, SMSNA
2009/11/16		SCIELE PHARMA, A SHIONOGI COMPANY, TO ACQUIRE ADDRENEX PHARMACEUTICALS, INC., A U.S. SPECIALTY PHARMACEUTICAL COMPANY
2009/11/10		Audio Webcasting of Conference Call for the Second Quater of Fiscal Year 2009

Press Release Index

Shionogi & Co., Ltd. has continuously supplied superior pharmaceuticals to people everywhere, based on its company policy to “constantly strive to provide medicine of the best possible kind essential for protection of the health of the people.